QuestionSBA
QuestionChoice
Heparin (i.e. “unfractionated”) bolus dose of 5000 units should be given in cases of patients who are to receive the percutaneous coronary intervention (PCI) for their STEMI. It is not considered an immediate pharmacotherapy.
10005262
b
Unfractionated heparin
QuestionChoice
This drug is a glycoprotein IIb/IIIa inhibitor. These drugs are used alongside heparin at the time of PCI among patients who have high-risk clinical and angiographic characteristics or who continue to have ischemia despite other treatments.
10005264
d
Tirofiban
QuestionChoice
Bivalirudin is a direct thrombin inhibitor. It may be considered as an alternative to glycoprotein IIb/IIIa inhibition and heparin among patients with acute coronary syndromes undergoing PCI with clinical features associated with an increased risk of bleeding or requiring femoral instead of radial access.
10005265
e
Bivalirudin
QuestionChoice
The most likely diagnosis here is ST-elevation myocardial infarction (STEMI). NICE guideline NG185 states that in the treatment of this, you should offer a 300mg loading dose of aspirin as soon as possible and continue aspirin indefinitely unless contraindicated.
10005261
a
Aspirin
QuestionChoice
Beta-blockers are generally reserved for secondary prevention following STEMI. They are appropriate lifelong therapies in haemodynamically stable patients with reduced left ventricular systolic function (left ventricular ejection fraction < 40%) unless contraindicated. In those without reduced LVEF, it may be appropriate to discontinue beta-blocker therapy after 12 months.
10005263
c
Atenolol
Concept
Chapter
2693
3713
Myocardial infarction and Acute Coronary Syndrome (ACS)
Topic
134
Cardiology
13599
A 60-year-old male lifelong smoker presents to the emergency department with crushing, central 10/10 chest pain which radiates to his left jaw. His ECG reveals ST elevation in V3-V6.

Which of the following is the most appropriate immediate pharmacotherapy?
a